Hib vaccine

From Wikipedia, the free encyclopedia

Haemophilus influenzae type b vaccine (Hib vaccine or PRP vaccine[1]) is a conjugate vaccine developed for the prevention of invasive disease caused by Haemophilus influenzae type b bacteria. The Centers for Disease Control and Prevention (CDC) has made recommendations for the use of the Hib vaccine[2]. Due to routine use of the Hib vaccine in the U.S. from 1980 to 1990, the incidence of invasive Hib disease has decreased from 40-100 per 100,000 children down to 1.3 per 100,000[3]. Vaccinations against Haemophilus influenzae (Hib) have decreased early childhood meningitis significantly in developed countries and recently in developing countries [4].

[edit] References

  1. ^ Haemophilus influenzae Type b Conjugate Vaccine (Meningicoccal Protein Conjugate): Immunogenicity and Safety at Various Doses
  2. ^ CDC:Recommendation of the Immunization Practices Advisory Committee (ACIP) Polysaccharide Vaccine for Prevention of Haemophilus influenzae Type b Disease
  3. ^ CDC: Haemophilus influenzae Serotype b (Hib) Disease
  4. ^ GAVI Alliance: Deadly Disease Eliminated in Children under Five Years of Age in Uganda

[edit] See also

v • d • e
Vaccines, Vaccination, Immunization, and Inoculation
Development
Administration
Live vaccines
Anthrax • BCG • Flu • MMR • MMRV • Polio(OPV) • Smallpox • Varicella • Yellow fever
Inactivated/toxoid vaccines
inactivated virus: Flu • HAV • Polio(IPV) •• inactivated bacteria/toxoid: DTwP •• conjugate: Hib • PCV
Other vaccines
subunit: Anthrax • DTaP • HPV •• recombinant DNA: HBV •• other: Anthrax • PPV
Controversy
See also
Languages